105 filings
Page 3 of 6
8-K
caay59rvuytvw71
29 Nov 22
Regulation FD Disclosure
9:00am
8-K
4thtv0952eeriuhz
21 Nov 22
Regulation FD Disclosure
9:00am
8-K
td5nlp3 st
8 Nov 22
Caribou Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update
4:05pm
8-K
f335aw28
3 Nov 22
Caribou Biosciences to Present ANTLER Trial-in-Progress Poster at the 64th American Society of Hematology Annual Meeting
9:00am
8-K
ad8ooefmgnqb0xfv
18 Oct 22
Regulation FD Disclosure
9:00am
8-K/A
jrnquxn2u7g5 bbl
22 Sep 22
Submission of Matters to a Vote of Security Holders
6:42pm
8-K
rkh8nkb0xv4waoagq 2x
22 Sep 22
Submission of Matters to a Vote of Security Holders
4:05pm
EFFECT
l81a j1ac
17 Aug 22
Notice of effectiveness
12:15am
8-K
qg2jxqq0oef oz
12 Aug 22
Entry into a Material Definitive Agreement
4:02pm
CORRESP
8p56ac3lcegphbc6yx
12 Aug 22
Correspondence with SEC
12:00am
DEFA14A
84qaqw2aaizpv9n 6pr
11 Aug 22
Additional proxy soliciting materials
4:09pm
DEFA14A
9umo6u zl
11 Aug 22
Additional proxy soliciting materials
4:06pm
DEF 14A
5y9kax0diqxy9ha
11 Aug 22
Definitive proxy
4:04pm
UPLOAD
95kgu
11 Aug 22
Letter from SEC
12:00am
S-3
p1t82 kt8b
9 Aug 22
Shelf registration
12:00am
8-K
h7clll0qld8 8ehw
9 Aug 22
Caribou Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
12:00am
8-K/A
5ds6qq8 so9xk
18 Jul 22
Departure of Directors or Certain Officers
4:04pm
8-K
40qzuhu8hv8v3
15 Jul 22
Other Events
4:06pm